Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Reumatología
Print version ISSN 0121-8123
Abstract
PINEROS CASTILLO, Joaquín Arturo; AREVALO ROA, Helbert Orlando and MUNOZ-GALINDO, Iván Mauricio. Management results of a cohort of rheumatoid arthritis patients in a specialized comprehensive healthcare institution in Colombia. Rev.Colomb.Reumatol. [online]. 2022, vol.29, n.2, pp.93-100. Epub Feb 21, 2023. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2021.01.009.
Objective:
To determine the management results in a cohort of patients with rheumatoid arthritis in a specialized integral healthcare institution for this disease in Colombia.
Materials and methods:
Descriptive cross-sectional study based on a cohort of rheumatoid arthritis patients according to ACR/EULAR 2010 criteria. The information was analysed based on consolidated data from clinical records and national reports in the period 2015-2018. Administrative records related to medication authorizations and prescriptions were considered. Sociodemographic variables, outcome indicators related to disease activity status and medication use percentage were evaluated.
Results:
As of June 30th 2018, 698 patients were identified, of which the female sex represented 83.8%, the general average age was 55.47 years, and the highest number of cases were in the 60-64 year age group. Of the patients, 68.3% were between remission and low disease activity. Seventy-three point one percent were managed with conventional disease-modifying antirheumatic drugs and a reduction in the use of biological therapy was recorded from 27.2% in 2016 to 17.8% at the end of the period.
Conclusions:
This study presents the management results of a comprehensive care model for patients with rheumatoid arthritis in Colombia, which managed to maintain the highest proportion of patients in low activity and remission as they had a longer follow-up time, to decrease the percentage of biological DMARDs use, and establish conventional DMARDs as the main therapeutic alternative.
Keywords : Rheumatoid arthritis; Antirheumatic agents; Healthcare programmes; Outcome assessment.